The mutations of WNK1 and WNK4 were shown to cause human genetic disease, the pseudohypoaldosteronism type 2 (also known as familial hyperkalemic hypertension or Gordon's syndrome) whose clinical phenotypes are characterized by hypertension and hyperkalemia 4. Here, WNK4 is linked to pseudohypoaldosteronism type 2.